NYGC: Thomas Lehner

Thomas Lehner has been appointed as scientific director of neuropsychiatric disease genomics at the New York Genome Center. He will join the center on Jan. 6, 2020. Lehner comes to the NYGC from the National Institute of Mental Health, where he was most recently director of the Office of Genomics Research Coordination and senior genomics advisor of the intramural research program. Prior to joining NIMH in 2004, he held academic research positions at Columbia University and at Rockefeller University. He also worked at Millennium Pharmaceuticals and for the New York State government. Lehner holds a PhD in human biology and genetics from the University of Vienna and a master's degree of public health from Columbia University.